---
schema_version: "secwatch.filing_event.v1"
accession: "0000012208-22-000080"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T02:58:05.090304+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad repurchases $67.1M of Class A shares QTD through Nov 8, 2022

## Summary
- Remaining repurchase authorization: $231.0M as of Nov 8, 2022.
- QTD repurchases: $67.1M at avg price $368.40/share (182,228 shares).
- Previous remaining at Sept 30, 2022 was $298.1M.
- Buybacks under program authorized by board in Nov 2017, Jul 2020, Jul 2022 for up to $650M total.

## SEC filing metadata
- accession: 0000012208-22-000080
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000001220822000080/0000012208-22-000080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000001220822000080/bio-20221108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000012208-22-000080
- JSON: https://secwatch.observer/filing/0000012208-22-000080.json
- Plain text: https://secwatch.observer/filing/0000012208-22-000080.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.